Inception Return
(5/24/2005)
|
4.49 %
|
|
YTD Return
|
0.64 %
|
|
NAVPS
(3/24/2023)
|
$10.19
|
|
Change
|
$0.01 / 0.10 %
|
|
|
Growth of $10,000
(As of February 28, 2023)
|
|
MER
|
1.60 %
|
|
Assets ($mil)
|
$1,501.66
|
|
Rank (1Yr)
|
-
|
|
Std Dev (3Yr)
|
8.34 %
|
|
Volatility Ranking (3Yr)
|
4/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The objective of the fund is to provide a combination of regular U.S. dollar monthly income and modest capital growth. The fund invests primarily in U.S. fixed-income securities such as government and corporate bonds, notes, asset-backed securities and preferred shares. The fund also invests in high-quality equity securities of U.S. companies.
|
Fund Manager
RBC Global Asset Management Inc.
Portfolio Manager
Frank Gambino, RBC Global Asset Management Inc.
Brad Willock, RBC Global Asset Management Inc.
David Nava, RBC Global Asset Management Inc.
Sub-Advisor
Soo Boo Cheah, RBC Global Asset Management (UK) Limited
|
|
Asset Allocation
(As of November 30, 2022)
|
Sector Allocation
(As of November 30, 2022)
|
Geographic Allocation
(As of November 30, 2022)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Microsoft Corp | US Equity | Technology | United States | 2.75% |
| Apple Inc | US Equity | Technology | United States | 2.52% |
| United States Treasury 1.88% 15-Nov-2051 | Foreign Bonds | Fixed Income | United States | 1.91% |
| Bank of Nova Scotia UTD 3.950% Dec 01, 2022 | Cash and Equivalents | Cash and Cash Equivalent | United States | 1.73% |
| Alphabet Inc Cl A | US Equity | Technology | United States | 1.66% |
| Johnson & Johnson | US Equity | Healthcare | United States | 1.53% |
| United States Treasury 2.38% 15-Feb-2042 | Foreign Bonds | Fixed Income | United States | 1.37% |
| iShares JPMorgan USD EM Bond ETF (EMB) | Foreign Bonds | Exchange Traded Fund | Multi-National | 1.35% |
| UnitedHealth Group Inc | US Equity | Healthcare | United States | 1.29% |
| CVS Health Corp | US Equity | Healthcare | United States | 1.16% |
Performance Data
(As of February 28, 2023)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-2.74
|
-1.73
|
-0.63
|
0.64
|
-9.66
|
2.66
|
3.41
|
4.60
|
|
Benchmark
|
-2.95
|
0.10
|
1.52
|
2.23
|
-10.49
|
2.37
|
2.52
|
4.46
|
|
Quartile Ranking
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Calendar Return (%)
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
2013
|
|
Fund
|
-14.77
|
11.18
|
10.88
|
14.85
|
-3.54
|
10.07
|
6.67
|
-1.15
|
7.38
|
9.54
|
|
Benchmark
|
-17.27
|
6.94
|
13.35
|
17.91
|
-5.58
|
16.32
|
5.51
|
-1.74
|
2.93
|
10.87
|
|
Quartile Ranking
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|